PreludeDx to Present New Data on the Clinical Utility of DCISionRT in Australian Patients with DCIS at the 2023 San Antonio Breast Cancer Symposium
05. Dezember 2023 07:00 ET
|
PreludeDx
In data presented at SABCS23, DCISionRT changed radiation therapy decisions in 41% of DCIS patients
PreludeDx™ to Present Multiple Presentations at the 2023 San Antonio Breast Cancer Symposium
16. November 2023 07:30 ET
|
PreludeDx
PreludeDx today announced that data will be presented in two separate poster presentations at the 2023 San Antonio Breast Cancer Symposium (SABCS).
UPDATE - PreludeDx Presents Risk Assessments for DCIS Patients Using Clinicopathologic-Based Models Like RTOG 9804 and MSKCC Compared to DCISionRT®
02. Oktober 2023 10:17 ET
|
PreludeDx
LAGUNA HILLS, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced study...
PreludeDx™ to Present New DCISionRT® Comparative Data in Oral Session at ASTRO 2023 Annual Meeting
19. September 2023 07:30 ET
|
PreludeDx
LAGUNA HILLS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it...
Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance
02. April 2014 08:30 ET
|
Atossa Genetics Inc.
SEATTLE, WA--(Marketwired - Apr 2, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Ben R. Chen has joined the Company as Senior Vice President of Global Regulatory Affairs and...
Atossa Genetics to Present at the 2013 Aegis Capital Healthcare Conference
24. September 2013 10:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, Chief Financial Officer & General Counsel,...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference & Exhibition
19. September 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 19, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference...
Atossa Genetics Co-Sponsors Los Angeles Premiere of Decoding Annie Parker, Starring Helen Hunt
16. September 2013 09:24 ET
|
Atossa Genetics
LOS ANGELES, CA--(Marketwired - Sep 16, 2013) - Seattle-based Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced its sponsorship of the Los Angeles premiere of...
Atossa Genetics Featured on FoxNews.com
12. September 2013 11:17 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 12, 2013) - The ForeCYTE Breast Health Test, the flagship product of Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, was featured in a video...
Atossa Genetics and Its Subsidiary the National Reference Laboratory for Breast Health to Exhibit Their Products and Services at Two Upcoming Conferences
21. August 2013 17:29 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 21, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS) and its subsidiary The National Reference Laboratory for Breast Health (NRLBH), will display their products and...